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SCLERODERMA RENAL CRISIS IN PROGRESSIVE 
SYSTEMIC SCLEROSIS: A CASE REPORT 
Atsuko Furukawa, Katsuyoshi Hashine, Tadayuki Miyamoto, Masato Tamura, 
Akira Numata, Makoto Yuasa and Akio Imagawa 
From the Department of Urology, Takamatsu Red Cross Hospital 
Susumu Kagawa 
From the Department of Urology, School of Medicine, Tokushima University 
We report a case of progres~ive systemic sclerosis with scleroderma renal crisis 10 years 
after onset. The patient (female) had progressive renal dysfunction, hypertension which was 
difficult to control, and massive gastrointestinal bleeding. An angiotensin converting enzyme 
inhibitor (enalapril) could not control her hypertension. Only intravenous nicardipine had a 
slight effect on her hypertension. Hemodialysis and plasma exchange, did not reverse the renal 
crisis, and the patient died. Microscopic examination of her kidney showed thickening of the 
capillary walls and mild nephrosclerosis. 
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INTRODUCTION 
Scleroderma renal crisis is a common 
cause of death in patients with progressive 
systemic sclerosis. It is usually accompa-
nied by malignant hypertension. Angio-
tensin converting enzyme inhibitors are 
thought to be effective. However, we re-
port a case of progressive systemic sclero-
sis with scleroderma renal crisis on whom 
an angiotensin converting enzyme inhibi-
tor (enalapril) was not effective. 
CASE REPORT 
A 37-year-old female noticed edema, chills 
in the fingers and Raynaud's phenome-
non in 1979. She was diagnosed as having 
progressive systemic sclerosis in 1982 and 
was treated primarily with urokinase and 
prostaglandin El for five years. However, 
since 1986, she had not received any medi-
cation. In February 1989, she showed gen-
eral fatigue and dyspnea, and was found 
to have renal dysfunction and hyperten 
sion. . On March I I, 1989, she required in-
stitutionalization in another hospital for he-
modialysis. She was admitted to our hos-
pital on March 14, 1989, due to massive 
bleeding from the stomach and intestine. 
On physical examination, her face was 
mask-like, her lips were dry and her mouth 
opened with difficulty. Her skin was dry 
and tight, but she had no ulcers or scars 
on her fingers. 
The laboratory data included white blood 
cell count of 30,900/mm3, hemoglobin 
value of 9.5 gldl, platelet count of 9.5 x 104/ 
mm3, bleeding time of 7 minutes 30 sec-
onds, and erythrocyte sedimentation rate 
of 7 mm/hr. Serological examination in-
cluded serum creatinine level of 9.45 mg/dl, 
blood urea nitrogen of 174.9 mg/dl, bicar-
bonate of 10.7 mEq/l, creatinine clearance 
of 1.7 I/day, and plasma renin activity of 
31.78 ng/ml/hr. Urinalysis revealed protein-
uria of 0.88 g/day. Immunological exam in-
a t ion revealed tha t the ant inuclear factor 
(ANF) was weakly positive in speckled pat-
tern at a 1: 80 titer, and none of the other 
specific antibody levels were significantly 
high. 
Fresh blood, platelet transfusion and 
gabexate mesilate were administered for 
treatment of disseminated intravascular 
coagulation (DIe). However, bleeding 
from the intestine still continued (Fig. 1). 
She was given nicardipine, nifedipine 
and enalapril to control her blood pressure. 
Because oral administration of antihyper-
tensive drugs was not possible due to gas-
trointestinal bleeding she was administered 
nicardipine intravenously. During the 
1452 Acta Urol. Jpn. Vol. 36, No. 12, 1990 
Fresh whole blood ~ Q:Q ~ c!J r:'-=-= 
01 10 ~Dc:::J CJ 
o o C! 
Fr .. h - frozen ple.ml 
eor-t,oted ,ed .... 
Platelet concentrate UO==== ==0 
"" """ 












0-0 body _ . (OC) 
.-. PLT(X 1000/ mm') 
4/1 
Fig. 1. Clinical course 
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Fig. 2. Blood pressure during the clinical course. 
course of therapy, her blood pressure re-
mained high despite a variety of antihyper-
tensive medications (Fig. 2) . 
Despite almost daily hemodialysis, as a 
treatment for renal failure, as well as plas-
ma exchange for the progressive systemic 
sclerosis itself, she eventually died of DIG. 
Microscopic examination of her kidney 
showed thickening of the capillary walls, 
which indicated mild nephrosclerosis (Fig . 
3). 
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Fig. 3. Renal autopsy showing thickening of 
the capillary walls. (HE x 10) 
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DISCUSSION 
Scleroderma renal crisis is the rapid de-
terioration of the renal function with ma-
lignant hypertension found in patients with 
progressive systemic sclerosis. It is still an 
important and often fatal complication for 
these patients. Brown et al. reported that 
7 % of progressive systemic sclerosis pa· 
tients developed this complication3), and 
according to Traub et al., it was present 
in 8.3 % of all cases4). 
The factors predicting scleroderma re-
nal crisis are thought to be: a relatively 
short duration from onset of progressive 
systemic sclerosis, urinalysis abnormalities-
such as hematuria and proteinuria, malig-
nant hypertension, high renin value and 
decreasing renal plasma flow. However, 
neither clinical nor laboratory findings are 
significan tt). Steen and her co-workers re-
ported that rapid progression of skin thick-
ening and early onset of anemia were 
likely to be warning signsS). 
Several treatments for scleroderma renal 
crisis have been tried, such as hemodialysis 
after nephrectomy, kidney transplantation 
and antihypertensive drugs4). However, 
recent studies showed that the most effec-
tive therapy for scleroderma renal crisis 
was the administration of angiotensin con-
verting enzyme inhibitors2 ,6-8). The admi-
nistration of other antihypertensive drugs, 
such as nifedipine and prazosin, not used 
in combination with angiotensin convert 
ing enzyme inhibitors are thought to be 
ineffective8 ,9) • 
Ejima et al. listed the patients with scle-
roderma renal crisis who had been treated 
by angiotensin converting enzyme inhibit-
ors reported before 1987. Most of the 
patients who took angiotensin converting 
enzyme inhibitors before severe renal dys-
function appeared, survived9). 
In our patient, the renal function had 
already been severely deteriorated and 
DIC had occurred when she was admitted 
to the hospital. In addition, intestinal 
bleeding rendered the oral administration 
of enalapril ineffective, which ultimately 
caused the malignant hypertension to con-
tinue. The causes of death were thought 
to be uncontrolled DIC and malignant hy-
pertension. 
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発症より10年後腎クリーゼにて急性腎不全を起こし
た進行性全身性硬化症の1例 を経験した.急激な腎機
能低下,コ ントロール不良な高血圧,大量の消化管出
血を認め,治療開始約1カ 月後死亡した.本症例では
入院時すでにDICと 腎不全が高度であったこと,消
化管出血によりアンギオテンシン変換酵素阻害剤であ
るenalaprilが経口投与できなかったことが予後不良
であった原因と考えられた.剖 検時の腎の光顕所見で
動脈内膜の肥厚と軽度の腎硬化像が認められた.
(泌尿紀要36:1451-1454,1990)
